Polaris Market Research has introduced the latest market research report titled U.S. Next-Generation Sequencing Library Preparation Market Size, Share, Trends, Industry Analysis Report By Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), By Product, By Application, By End Use – Market Forecast, 2025–2034 that highlights the major revenue stream for the forecast period. The report contains clear, reliable, and thorough U.S. Next-Generation Sequencing Library Preparation Market data and information that will undoubtedly help businesses to develop and boost return on investment (ROI). The report focuses on U.S. Next-Generation Sequencing Library Preparation market size, share, growth status, future trends, volume, and key market dynamics. The report identifies essential customer attributes in order to identify various demands throughout the industry. Then, the market competition is determined along with various activities performed by key companies in the market.

The report demonstrates a statistical overview of the current market condition, future prospects, latest technological advancements, and opportunities-challenges of top key players. Further, the region that is expected to produce the greatest potential in the market is mentioned in the analysis report. As per U.S. Next-Generation Sequencing Library Preparation market segmentation by type, application, and region, this report provides accurate calculations and forecasts for consumption value in terms of volume and value. Market dynamics (mainly covering drivers, restraints, and opportunities) give crucial information for understanding the market.

U.S. Next-Generation Sequencing Library Preparation Market size and share is currently valued at USD 649.42 million in 2024 and is anticipated to generate an estimated revenue of USD 2,167.71 Million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 12.83% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034

Study Explore:

• Historical and recent key insights
• Market size by company, key regions/countries
• Driving forces and roadblocks
• Value chain analysis with price analysis and forecast
• New prospects and targeted marketing methodologies
• R&D and the demand for new product launches and applications.
• New Project Investment Feasibility Analysis

Competitive Landscape Analysis

The report enfolds top competitors’ analysis where U.S. Next-Generation Sequencing Library Preparation key players are covered along with competitor’s strategy, sales, cost of production, standing position on the market organization size, share, growth, product line in the market, the financial status of competitors, and future expectation data throughout the forecast period. The study notes the reactions of competitors and enables business players to stay innovative and reduce business risks. Through this, players will be able to avoid repetitive mistakes in the business.

Top Players:

• Agilent Technologies, Inc.
• BD
• F. Hoffmann-La Roche AG, Inc.
• Illumina, Inc.
• New England Biolabs Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• QIAGEN N.V.
• Revvity, Inc.
• Thermo Fisher Scientific Inc.
• Twist Bioscience

Market Growths:

The U.S. Next-Generation Sequencing Library Preparation Market is experiencing rapid growth due to the increasing applications of NGS in precision medicine, oncology, rare disease diagnostics, and biomarker discovery. Falling sequencing costs, higher accuracy, and automation of library preparation workflows are driving adoption in research laboratories, hospitals, and diagnostic centers. High-throughput platforms, reagent kits, and automation systems simplify complex sample preparation processes, enabling faster and more reliable sequencing results. Rising investments in genomic research, government initiatives supporting precision medicine, and the growing prevalence of cancer and genetic disorders further fuel demand. The market benefits from increasing collaborations between sequencing platform providers, pharmaceutical companies, and research institutions to develop novel assays and improve library preparation technologies. The demand for personalized medicine and companion diagnostics in clinical applications is also a key growth driver. Additionally, advancements in single-cell sequencing and transcriptomics are creating new opportunities within library preparation solutions. Continuous innovation, coupled with growing adoption of NGS in clinical and research settings, is expected to sustain market growth over the forecast period, making the U.S. a leading contributor to the global NGS library preparation market.